Compare MRVI & BLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | BLE |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.0M | 499.7M |
| IPO Year | 2020 | N/A |
| Metric | MRVI | BLE |
|---|---|---|
| Price | $3.80 | $10.46 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.57 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 108.3K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $192,435,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | ★ N/A | $1,082.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.67 | $8.77 |
| 52 Week High | $6.05 | $10.95 |
| Indicator | MRVI | BLE |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 50.25 |
| Support Level | $3.66 | $10.40 |
| Resistance Level | $3.99 | $10.55 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 34.78 | 30.95 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Blackrock Municipal Income Trust II is a perpetual closed-end municipal bond fund. Its objective is to provide a high current income exempt from federal income taxes. The fund invests a majority of its managed assets in municipal obligations issued by or on behalf of states, territories, and possessions of the United States and their political subdivisions, agencies, or instrumentalities (Municipal Bonds), the interest of which is exempt from regular federal income tax (except that the interest may be subject to the alternative minimum tax).